Laxxon Medical to Join 23rd Annual Needham Virtual Health Conference

New York-based Laxxon Medical, a notable player in the pharma-technology sector, will participate in the upcoming 23rd Annual Needham Virtual Health Conference. Scheduled for April 8-11, 2024, the event will concentrate on major innovations within the Biopharma, Medtech, Diagnostics, and Digital Health industries. Laxxon Medical aims to showcase its latest advances in pharmaceutical technology, representing a significant step towards innovative drug delivery methods.

The company's top executives, CEO/Chairman Helmut Kerschbaumer and Chief Strategy Officer Alexander Ruckdaeschel, are set to engage in personal dialogues with a diverse group of investors, including those from institutional, private equity, and venture capital backgrounds. This participation underscores Laxxon Medical's strategic efforts to broaden its visibility and potentially foster new collaborations in the health tech arena.

Amid a gathering of leading entities from various sectors of healthcare, Laxxon Medical will highlight its pioneering work with SPID®, a cutting-edge 3D screen printing technology designed for pharmaceutical applications. It boasts a robust pipeline of collaborations and patented products aimed at revolutionizing patient care. The company holds an impressive proprietary portfolio with 150 patents and over 3,000 patent claims to its name, pointing towards a promising future in drug delivery advancements.